<?xml version="1.0" encoding="UTF-8"?>
<iati-activities version="2.03">
 <iati-activity default-currency="USD" hierarchy="1" humanitarian="0" iati-activities:version="2.03" xml:lang="EN" xmlns:iati-activities="http://d-portal.org/xmlns/iati-activities">
  <iati-identifier>US-EIN-04-2103547-BioVersys</iati-identifier>
  <reporting-org ref="US-EIN-04-2103547" type="80">
   <narrative xml:lang="EN">Boston University</narrative>
  </reporting-org>
  <title>
   <narrative xml:lang="EN">BioVersys - Anti-Virulence Adjunctive Therapy Against Resistant Staphylococus aureus (AVATAR-SA)</narrative>
  </title>
  <description type="1">
   <narrative xml:lang="EN">Anti-Virulence Adjunctive Therapy Against Resistant Staphylococus aureus (AVATAR-SA)</narrative>
  </description>
  <participating-org role="4" type="70">
   <narrative xml:lang="EN">BioVersys</narrative>
  </participating-org>
  <activity-status code="2"></activity-status>
  <activity-date iso-date="2019-11-01" type="2"></activity-date>
  <activity-date iso-date="2021-04-30" type="4"></activity-date>
  <recipient-country code="CH" percentage="100"></recipient-country>
  <sector code="12250" percentage="100" vocabulary="1"></sector>
  <budget status="2" type="1">
   <period-start iso-date="2019-11-01"></period-start>
   <period-end iso-date="2020-03-31"></period-end>
   <value currency="USD" value-date="2020-02-04">1969092</value>
  </budget>
  <transaction>
   <transaction-type code="4"></transaction-type>
   <transaction-date iso-date="2021-10-21"></transaction-date>
   <value currency="USD" value-date="2021-10-21">1844557.34</value>
  </transaction>
 </iati-activity>
</iati-activities>
